156 related articles for article (PubMed ID: 34452564)
1. Lung Cancer Survival with Current Therapies and New Targeted Treatments: A Comprehensive Update from the Srinagarind Hospital-Based Cancer Registry from (2013 to 2017).
Musika W; Kamsa-Ard S; Jirapornkul C; Santong C; Phunmanee A
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2501-2507. PubMed ID: 34452564
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Treatment, Survival Rates, and Factors related to Survival of Stage III Lung Cancer Patients Treated at Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, Thailand.
Raksasri N; Kamsa-Ard S; Musika W; Santong C; Phunmanee A
Asian Pac J Cancer Prev; 2023 May; 24(5):1743-1749. PubMed ID: 37247297
[TBL] [Abstract][Full Text] [Related]
3. Improvement in population-based survival of stage IV NSCLC due to increased use of chemotherapy.
Aarts MJ; van den Borne BE; Biesma B; Kloover JS; Aerts JG; Lemmens VE
Int J Cancer; 2015 Mar; 136(5):E387-95. PubMed ID: 25219898
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: a SEER cancer registry analysis.
Hansen RN; Zhang Y; Seal B; Ryan K; Yong C; Darilay A; Ramsey SD
BMC Cancer; 2020 Apr; 20(1):276. PubMed ID: 32248816
[TBL] [Abstract][Full Text] [Related]
5. Survival of Cancer Patients with Co-Morbid Tuberculosis in Thailand.
Siewchaisakul P; Nanthanangkul S; Santong C; Suwanrungruang K; Vatanasapt P
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2701-2708. PubMed ID: 34452577
[TBL] [Abstract][Full Text] [Related]
6. Treatment Patterns and Overall Survival Associated with First-Line Systemic Therapy for Patients with Advanced Non-Small Cell Lung Cancer.
Spence MM; Hui RL; Chang JT; Schottinger JE; Millares M; Rashid N
J Manag Care Spec Pharm; 2017 Feb; 23(2):195-205. PubMed ID: 28125366
[TBL] [Abstract][Full Text] [Related]
7. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
Wang J; Wu N; Lv C; Yan S; Yang Y
J Cancer Res Clin Oncol; 2019 Feb; 145(2):463-469. PubMed ID: 30474757
[TBL] [Abstract][Full Text] [Related]
8. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
9. Screening for patients with non-small cell lung cancer who could survive long term chemotherapy.
Wu XY; Huang XE
Asian Pac J Cancer Prev; 2015; 16(2):647-52. PubMed ID: 25684501
[TBL] [Abstract][Full Text] [Related]
10. Patient, tumor, and healthcare factors associated with regional variability in lung cancer survival: a Spanish high-resolution population-based study.
Rodríguez-Barranco M; Salamanca-Fernández E; Fajardo ML; Bayo E; Chang-Chan YL; Expósito J; García C; Tallón J; Minicozzi P; Sant M; Petrova D; Luque-Fernandez MA; Sánchez MJ
Clin Transl Oncol; 2019 May; 21(5):621-629. PubMed ID: 30341474
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer.
Yang ZY; Liu L; Mao C; Wu XY; Huang YF; Hu XF; Tang JL
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD009948. PubMed ID: 25400254
[TBL] [Abstract][Full Text] [Related]
12. Statins use and its impact in EGFR-TKIs resistance to prolong the survival of lung cancer patients: A Cancer registry cohort study in Taiwan.
Nguyen PA; Chang CC; Galvin CJ; Wang YC; An SY; Huang CW; Wang YH; Hsu MH; Li YJ; Yang HC
Cancer Sci; 2020 Aug; 111(8):2965-2973. PubMed ID: 32441434
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting survival of cervical cancer patients treated at the radiation unit of Srinagarind Hospital, Khon Kaen University, Thailand.
Pomros P; Sriamporn S; Tangvoraphonkchai V; Kamsa-Ard S; Poomphakwaen K
Asian Pac J Cancer Prev; 2007; 8(2):297-300. PubMed ID: 17696750
[TBL] [Abstract][Full Text] [Related]
14. Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry.
Lakomy R; Poprach A; Bortlicek Z; Melichar B; Chloupkova R; Vyzula R; Zemanova M; Kopeckova K; Svoboda M; Slaby O; Kiss I; Studentova H; Juracek J; Fiala O; Kopecky J; Finek J; Dusek L; Hejduk K; Buchler T
BMC Cancer; 2017 Dec; 17(1):880. PubMed ID: 29268716
[TBL] [Abstract][Full Text] [Related]
15. Survival rate of extrahepatic cholangiocarcinoma patients after surgical treatment in Thailand.
Pattanathien P; Khuntikeo N; Promthet S; Kamsa-Ard S
Asian Pac J Cancer Prev; 2013; 14(1):321-4. PubMed ID: 23534746
[TBL] [Abstract][Full Text] [Related]
16. Survival of cholangiocarcinoma patients in northeastern Thailand after supportive treatment.
Thunyaharn N; Promthet S; Wiangnon S; Suwanrungruang K; Kamsa-ard S
Asian Pac J Cancer Prev; 2013; 14(11):7029-32. PubMed ID: 24377644
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the Prognostic Factors and Survival Rates of Endometrial Cancer Patients in a Tertiary Referral Hospital in Northeast Thailand.
Wannasin R; Thinkhamrop K; Kelly M; Likitdee N
Asian Pac J Cancer Prev; 2024 Feb; 25(2):671-679. PubMed ID: 38415555
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer.
Liao WY; Chen JH; Wu M; Shih JY; Chen KY; Ho CC; Yang JC; Yu CJ
Clin Lung Cancer; 2013 Jul; 14(4):418-24. PubMed ID: 23291258
[TBL] [Abstract][Full Text] [Related]
19. Demographic differentials of lung cancer survival in Bangladeshi patients.
Islam MR; Hasan ATMK; Khatun N; Ridi IN; Rasheed MMO; Islam SMA; Karim MN
PLoS One; 2021; 16(12):e0261238. PubMed ID: 34890415
[TBL] [Abstract][Full Text] [Related]
20. Evidence That Established Lung Cancer Mortality Disparities in American Indians Are Not Due to Lung Cancer Genetic Testing and Targeted Therapy Disparities.
Begnaud A; Yang P; Robichaux C; Rubin N; Kratzke R; Melzer A; Aliferis C; Jacobson P
Clin Lung Cancer; 2020 May; 21(3):e164-e168. PubMed ID: 31759888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
